Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organovo

0.4039
-0.0217-5.10%
Post-market: 0.41500.0111+2.75%17:33 EDT
Volume:356.88K
Turnover:145.55K
Market Cap:8.25M
PE:-0.50
High:0.4237
Open:0.4150
Low:0.4022
Close:0.4256
Loading ...

Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises

GlobeNewswire
·
06 Mar

Nasdaq Composite, S&P 500 Slide After Weaker-Than-Expected Data Stokes Worries About US Economy

MT Newswires Live
·
26 Feb

Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings

Benzinga
·
26 Feb

Eli Lilly Expands Zepbound Vial Dose Options, Cuts Weight-Loss Drug's Prices for Self-Pay Patients

MT Newswires
·
26 Feb

Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast

Benzinga
·
26 Feb

BRIEF-Organovo’S FXR Program, Including FXR314, To Be Acquired By Eli Lilly And Company

Reuters
·
25 Feb

Organovo Holdings Shares up 214% as Eli Lilly Acquires Co's Fxr Program

THOMSON REUTERS
·
25 Feb

BUZZ-U.S. STOCKS ON THE MOVE-  Eli Lilly, Krispy Kreme, PayPal

Reuters
·
25 Feb

BUZZ-Organovo rises as Eli Lilly acquires co's FXR program

Reuters
·
25 Feb

Organovo Holdings Shares More Than Triple Premarket After Eli Lilly to Buy Co's Liver and Bowel Disease Drug Program

THOMSON REUTERS
·
25 Feb

Organovo’s FXR program to be acquired by Eli Lilly

TIPRANKS
·
25 Feb

Organovo Holdings Inc - to Receive Upfront Payment and Milestones for Fxr314

THOMSON REUTERS
·
25 Feb

Organovo’s Fxr Program, Including Fxr314, to Be Acquired by Eli Lilly and Company

THOMSON REUTERS
·
25 Feb

Organovo Holdings Inc - Lilly Acquires All Commercial and Ip Rights to Fxr Program

THOMSON REUTERS
·
25 Feb

Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company

GlobeNewswire
·
25 Feb

Organovo Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
22 Feb